Primum non nocere - Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)?
Rev. saúde pública (Online); 54 (), 2020
ABSTRACT Chloroquine (CQ) and its analog hydroxychloroquine (HCQ) were recently included in several clinical trials as potential prophylactic and therapeutic options for SARS-COV-2 infection/covid-19. However, drug effectiveness in preventing, treating, or slowing the progression of the disease is still ...
Antimaláricos/efectos adversos, Antimaláricos/farmacocinética, Antimaláricos/farmacología, Betacoronavirus/efectos de los fármacos, COVID-19, Cloroquina/efectos adversos, Cloroquina/farmacocinética, Cloroquina/farmacología, Contraindicaciones de los Medicamentos, Infecciones por Coronavirus/tratamiento farmacológico, Hidroxicloroquina/efectos adversos, Hidroxicloroquina/farmacocinética, Hidroxicloroquina/farmacología, Pandemias, Neumonía Viral/tratamiento farmacológico, Medición de Riesgo, SARS-CoV-2